moxifloxacin has been researched along with riboflavin in 5 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (riboflavin) | Trials (riboflavin) | Recent Studies (post-2010) (riboflavin) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 9,345 | 389 | 3,015 |
| Protein | Taxonomy | moxifloxacin (IC50) | riboflavin (IC50) |
|---|---|---|---|
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ben Eliahu, S; Kleinmann, G; Litvin, G; Marcovich, AL; Rotenberg, M; Zadok, D | 1 |
| Akyar, I; Celik, E; Cosar, CB; Gonen, T; Ince, U; Kucuk, M; Serteser, M; Tokat, F | 1 |
| Austin, AF; Keenan, JD; Lalitha, P; Lietman, TM; Liu, Z; Narayana, S; Porco, TC; Prajna, NV; Radhakrishnan, N; Rajaraman, R; Rose-Nussbaumer, J | 1 |
1 review(s) available for moxifloxacin and riboflavin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for moxifloxacin and riboflavin
| Article | Year |
|---|---|
Cross-Linking Assisted Infection Reduction (CLAIR): A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Bacterial Keratitis.
Topics: Aged; Anti-Bacterial Agents; Bacteria; Collagen; Combined Modality Therapy; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Moxifloxacin; Photochemotherapy; Photosensitizing Agents; Riboflavin; Treatment Outcome; Ultraviolet Rays; Visual Acuity | 2021 |
3 other study(ies) available for moxifloxacin and riboflavin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Penetration of moxifloxacin through crosslinked corneas.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Collagen; Cornea; Cross-Linking Reagents; Fluoroquinolones; Moxifloxacin; Photosensitizing Agents; Rabbits; Riboflavin; Tissue Distribution; Ultraviolet Rays | 2014 |
Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Collagen; Colony Count, Microbial; Cornea; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Moxifloxacin; Photosensitizing Agents; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Riboflavin; Tissue Distribution | 2015 |